Please enable JavaScript to continue using this application.

Compare $FENC vs $XFOR | Chartloom

Compare

$FENC vs $XFOR

Fennec Pharmaceuticals Inc · X4 Pharmaceuticals Inc

FENC

Fennec Pharmaceuticals Inc

XFOR

X4 Pharmaceuticals Inc

Compare $FENC vs $XFOR

Comparing Fennec Pharmaceuticals Inc and X4 Pharmaceuticals Inc

FENCFennec Pharmaceuticals Inc

XFORX4 Pharmaceuticals Inc

FENCFennec Pharmaceuticals Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

18.55x

Forward P/S (NTM)

4.23x

Rev growth (TTM)

77.8%

YTD performance

39.5%

52W performance

16.2%

FCF yield

-0.5%

XFORX4 Pharmaceuticals Inc

Market cap

$274M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

28.09x

Rev growth (TTM)

-51.6%

YTD performance

-25.2%

52W performance

-12.3%

FCF yield

-32.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FENC

XFOR

Detailed metrics comparison

FENC

Fennec Pharmaceuticals Inc

XFOR

X4 Pharmaceuticals Inc

Market Cap

FENC$372M

XFOR$274M

Enterprise Value

FENC$331M

XFOR$156M

Price

FENC$10.71

XFOR$2.91

P/E Ratio

FENCN/A

XFORN/A

P/S Ratio

FENC6.28x

XFOR17.32x

EV/Sales

FENC5.59x

XFOR9.85x

EV/EBITDA

FENC111.97x

XFOR0.00x

P/B Ratio

FENC8.43x

XFOR1.81x

P/FCF Ratio

FENCN/A

XFORN/A

EV/FCF

FENC-162.16x

XFOR-1.76x

PEG Ratio

FENCN/A

XFORN/A

Forward P/E (NTM)

FENC18.55x

XFORN/A

Forward P/S (NTM)

FENC4.23x

XFOR28.09x

Revenue (TTM)

FENC$59M

XFOR$16M

Revenue Growth (YoY)

FENC77.8%

XFOR-51.6%

Forward Rev Growth

FENC42.8%

XFOR-27.7%

Gross Margin (TTM)

FENC93.7%

XFOR81.5%

Operating Margin (TTM)

FENC0.0%

XFOR0.0%

EBITDA Margin (TTM)

FENC-1.9%

XFOR-544.2%

Net Margin (TTM)

FENC-5.5%

XFOR-568.8%

FCF Margin (TTM)

FENC-3.4%

XFOR-560.0%

Net Income (TTM)

FENC$-3M

XFOR$-90M

FCF (TTM)

FENC$-2M

XFOR$-89M

EPS (TTM)

FENC-$0.09

XFOR-$0.71

ROE (TTM)

FENC-678.0%

XFOR-6305.0%

ROA (TTM)

FENC-486.0%

XFOR-3689.0%

ROIC (TTM)

FENC-678.0%

XFOR-4109.0%

Cash

FENC$41M

XFOR$195M

Debt

FENC$0

XFOR$77M

Net Cash/Debt

FENC$41M

XFOR$118M

Current Ratio (TTM)

FENC5.85x

XFOR11.30x

Quick Ratio (TTM)

FENC5.36x

XFOR10.87x

Debt/Equity (TTM)

FENC0.00x

XFOR0.49x

Debt/Assets (TTM)

FENC0.0%

XFOR0.0%

Interest Coverage (TTM)

FENCN/A

XFORN/A

Net Debt/EBITDA (TTM)

FENC0.00x

XFOR0.00x

Beta

FENC1.21

XFOR0.50

52W Performance

FENC16.2%

XFOR-12.3%

YTD Performance

FENC39.5%

XFOR-25.2%

% from 52W High

FENC-19.2%

XFOR-39.8%

% from 52W Low

FENC89.6%

XFOR7.8%

Asset Turnover (TTM)

FENC0.89x

XFOR0.06x

FCF Yield (TTM)

FENC-0.5%

XFOR-32.3%

Earnings Yield (TTM)

FENC-0.9%

XFOR-32.8%

Dividend Yield (TTM)

FENCN/A

XFORN/A

Rule of 40

FENC74.4

XFOR-611.6

EV/GP/RG

FENC0.12

XFORN/A

Ticker research

View FENC research View XFOR research

Metric	FENC Fennec Pharmaceuticals Inc	XFOR X4 Pharmaceuticals Inc
Market & Valuation
Market Cap	$372M	$274M
Enterprise Value	$331M	$156M
Price	$10.71	$2.91
P/E Ratio	N/A	N/A
P/S Ratio	6.28x	17.32x
EV/Sales	5.59x	9.85x
EV/EBITDA	111.97x	0.00x
P/B Ratio	8.43x	1.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-162.16x	-1.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	18.55x	N/A
Forward P/S (NTM)	4.23x	28.09x
Revenue & Growth
Revenue (TTM)	$59M	$16M
Revenue Growth (YoY)	77.8%	-51.6%
Forward Rev Growth	42.8%	-27.7%
Profitability
Gross Margin (TTM)	93.7%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-544.2%
Net Margin (TTM)	-5.5%	-568.8%
FCF Margin (TTM)	-3.4%	-560.0%
Net Income (TTM)	$-3M	$-90M
FCF (TTM)	$-2M	$-89M
EPS (TTM)	-$0.09	-$0.71
ROE (TTM)	-678.0%	-6305.0%
ROA (TTM)	-486.0%	-3689.0%
ROIC (TTM)	-678.0%	-4109.0%
Financial Health
Cash	$41M	$195M
Debt	$0	$77M
Net Cash/Debt	$41M	$118M
Current Ratio (TTM)	5.85x	11.30x
Quick Ratio (TTM)	5.36x	10.87x
Debt/Equity (TTM)	0.00x	0.49x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.50
52W Performance	16.2%	-12.3%
YTD Performance	39.5%	-25.2%
% from 52W High	-19.2%	-39.8%
% from 52W Low	89.6%	7.8%
Efficiency & Yields
Asset Turnover (TTM)	0.89x	0.06x
FCF Yield (TTM)	-0.5%	-32.3%
Earnings Yield (TTM)	-0.9%	-32.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	74.4	-611.6
EV/GP/RG	0.12	N/A
Ticker research	View FENC research	View XFOR research

Valuation

P/S Ratio

FENC

6.28x

XFOR

17.32x

EV/FCF

FENC

-162.16x

XFOR

-1.76x

Growth & revenue

Revenue Growth TTM

FENC

77.8%

XFOR

-51.6%

Forward Revenue Growth

FENC

42.8%

XFOR

-27.7%

Profitability & performance

Gross Margin

FENC

93.7%

XFOR

81.5%

ROE

FENC

-678.0%

XFOR

-6305.0%

FCF Yield %

FENC

-0.5%

XFOR

-32.3%

52-Week Performance

FENC

16.2%

XFOR

-12.3%

Detailed metrics comparison

FENC

Fennec Pharmaceuticals Inc

XFOR

X4 Pharmaceuticals Inc

Market Cap

FENC$372M

XFOR$274M

Enterprise Value

FENC$331M

XFOR$156M

Price

FENC$10.71

XFOR$2.91

P/E Ratio

FENCN/A

XFORN/A

P/S Ratio

FENC6.28x

XFOR17.32x

EV/Sales

FENC5.59x

XFOR9.85x

EV/EBITDA

FENC111.97x

XFOR0.00x

P/B Ratio

FENC8.43x

XFOR1.81x

P/FCF Ratio

FENCN/A

XFORN/A

EV/FCF

FENC-162.16x

XFOR-1.76x

PEG Ratio

FENCN/A

XFORN/A

Forward P/E (NTM)

FENC18.55x

XFORN/A

Forward P/S (NTM)

FENC4.23x

XFOR28.09x

Revenue (TTM)

FENC$59M

XFOR$16M

Revenue Growth (YoY)

FENC77.8%

XFOR-51.6%

Forward Rev Growth

FENC42.8%

XFOR-27.7%

Gross Margin (TTM)

FENC93.7%

XFOR81.5%

Operating Margin (TTM)

FENC0.0%

XFOR0.0%

EBITDA Margin (TTM)

FENC-1.9%

XFOR-544.2%

Net Margin (TTM)

FENC-5.5%

XFOR-568.8%

FCF Margin (TTM)

FENC-3.4%

XFOR-560.0%

Net Income (TTM)

FENC$-3M

XFOR$-90M

FCF (TTM)

FENC$-2M

XFOR$-89M

EPS (TTM)

FENC-$0.09

XFOR-$0.71

ROE (TTM)

FENC-678.0%

XFOR-6305.0%

ROA (TTM)

FENC-486.0%

XFOR-3689.0%

ROIC (TTM)

FENC-678.0%

XFOR-4109.0%

Cash

FENC$41M

XFOR$195M

Debt

FENC$0

XFOR$77M

Net Cash/Debt

FENC$41M

XFOR$118M

Current Ratio (TTM)

FENC5.85x

XFOR11.30x

Quick Ratio (TTM)

FENC5.36x

XFOR10.87x

Debt/Equity (TTM)

FENC0.00x

XFOR0.49x

Debt/Assets (TTM)

FENC0.0%

XFOR0.0%

Interest Coverage (TTM)

FENCN/A

XFORN/A

Net Debt/EBITDA (TTM)

FENC0.00x

XFOR0.00x

Beta

FENC1.21

XFOR0.50

52W Performance

FENC16.2%

XFOR-12.3%

YTD Performance

FENC39.5%

XFOR-25.2%

% from 52W High

FENC-19.2%

XFOR-39.8%

% from 52W Low

FENC89.6%

XFOR7.8%

Asset Turnover (TTM)

FENC0.89x

XFOR0.06x

FCF Yield (TTM)

FENC-0.5%

XFOR-32.3%

Earnings Yield (TTM)

FENC-0.9%

XFOR-32.8%

Dividend Yield (TTM)

FENCN/A

XFORN/A

Rule of 40

FENC74.4

XFOR-611.6

EV/GP/RG

FENC0.12

XFORN/A

Ticker research

View FENC research View XFOR research

Metric	FENC Fennec Pharmaceuticals Inc	XFOR X4 Pharmaceuticals Inc
Market & Valuation
Market Cap	$372M	$274M
Enterprise Value	$331M	$156M
Price	$10.71	$2.91
P/E Ratio	N/A	N/A
P/S Ratio	6.28x	17.32x
EV/Sales	5.59x	9.85x
EV/EBITDA	111.97x	0.00x
P/B Ratio	8.43x	1.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-162.16x	-1.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	18.55x	N/A
Forward P/S (NTM)	4.23x	28.09x
Revenue & Growth
Revenue (TTM)	$59M	$16M
Revenue Growth (YoY)	77.8%	-51.6%
Forward Rev Growth	42.8%	-27.7%
Profitability
Gross Margin (TTM)	93.7%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-544.2%
Net Margin (TTM)	-5.5%	-568.8%
FCF Margin (TTM)	-3.4%	-560.0%
Net Income (TTM)	$-3M	$-90M
FCF (TTM)	$-2M	$-89M
EPS (TTM)	-$0.09	-$0.71
ROE (TTM)	-678.0%	-6305.0%
ROA (TTM)	-486.0%	-3689.0%
ROIC (TTM)	-678.0%	-4109.0%
Financial Health
Cash	$41M	$195M
Debt	$0	$77M
Net Cash/Debt	$41M	$118M
Current Ratio (TTM)	5.85x	11.30x
Quick Ratio (TTM)	5.36x	10.87x
Debt/Equity (TTM)	0.00x	0.49x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.50
52W Performance	16.2%	-12.3%
YTD Performance	39.5%	-25.2%
% from 52W High	-19.2%	-39.8%
% from 52W Low	89.6%	7.8%
Efficiency & Yields
Asset Turnover (TTM)	0.89x	0.06x
FCF Yield (TTM)	-0.5%	-32.3%
Earnings Yield (TTM)	-0.9%	-32.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	74.4	-611.6
EV/GP/RG	0.12	N/A
Ticker research	View FENC research	View XFOR research